Blastomycosis Differential Diagnoses

1. Frost HM, Novicki TJ. Blastomyces antigen detection for diagnosis and management of Blastomycosis. J Clin Microbiol. 2015 Nov. 53 (11):3660-2. [QxMD MEDLINE Link]. [Full Text].

2. Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev. 2010 Apr. 23 (2):367-81. [QxMD MEDLINE Link].

3. Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol. 2012 May. 50 (5):1783-6. [QxMD MEDLINE Link].

4. Babady NE, Buckwalter SP, Hall L, Le Febre KM, Binnicker MJ, Wengenack NL. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011 Sep. 49 (9):3204-8. [QxMD MEDLINE Link]. [Full Text].

5. Richer SM, Smedema ML, Durkin MM, et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol. 2014 Feb. 21 (2):143-6. [QxMD MEDLINE Link]. [Full Text].

6. [Guideline] Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008 Jun 15. 46(12):1801-12. [QxMD MEDLINE Link].

7. Nemecek JC, Wüthrich M, Klein BS. Global control of dimorphism and virulence in fungi. Science. 2006 Apr 28. 312 (5773):583-8. [QxMD MEDLINE Link]. [Full Text].

8. Rooney PJ, Sullivan TD, Klein BS. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism. Mol Microbiol. 2001 Feb. 39 (4):875-89. [QxMD MEDLINE Link].

9. Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect. 1997 Sep. 12 (3):219-28. [QxMD MEDLINE Link].

10. Anderson JL, Meece JK, Hall MC, Frost HM. Evidence of delayed dissemination or re-infection with Blastomyces in two immunocompetent hosts. Med Mycol Case Rep. 2016 Sep. 13:9-11. [QxMD MEDLINE Link]. [Full Text].

11. Frost HM, Anderson J, Ivacic L, Meece J. Blastomycosis in children: an analysis of clinical, epidemiologic, and genetic features. J Pediatric Infect Dis Soc. 2017 Mar 1. 6 (1):49-56. [QxMD MEDLINE Link].

12. Sarosi GA, Eckman MR, Davies SF, Laskey WK. Canine blastomycosis as a harbinger of human disease. Ann Intern Med. 1979 Nov. 91 (5):733-5. [QxMD MEDLINE Link].

13. Hay RJ. Blastomycosis: what's new?. J Eur Acad Dermatol Venereol. 2000 Jul. 14 (4):249-50. [QxMD MEDLINE Link].

14. Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis. 1996 May. 22 suppl 2:S102-11. [QxMD MEDLINE Link].

15. McDonald R, Dufort E, Jackson BR, Tobin EH, Newman A, Benedict K, et al. Notes from the field: Blastomycosis cases occurring outside of regions with known endemicity - New York, 2007-2017. MMWR Morb Mortal Wkly Rep. 2018 Sep 28. 67 (38):1077-8. [QxMD MEDLINE Link]. [Full Text].

16. Zhu D, Chen H, Yu L. Probable pulmonary blastomyomycocis in an immunocompetent person. Int J Infect Dis. 2017 Jun. 59:86-9. [QxMD MEDLINE Link]. [Full Text].

17. Benedict K, Roy M, Chiller T, Davis JP. Epidemiologic and ecologic features of blastomycosis: a review. Curr Fungal Infect Rep. 2012 Dec. 6(4):327-35. [Full Text].

18. Seitz AE, Younes N, Steiner CA, Prevots DR. Incidence and trends of blastomycosis-associated hospitalizations in the United States. PLoS One. 2014. 9 (8):e105466. [QxMD MEDLINE Link]. [Full Text].

19. Khuu D, Shafir S, Bristow B, Sorvillo F. Blastomycosis mortality rates, United States, 1990-2010. Emerg Infect Dis. 2014 Nov. 20 (11):1789-94. [QxMD MEDLINE Link]. [Full Text].

20. Carlos WG, Rose AS, Wheat LJ, et al. Blastomycosis in indiana: digging up more cases. Chest. 2010 Dec. 138 (6):1377-82. [QxMD MEDLINE Link].

21. McTaggart LR, Brown EM, Richardson SE. Phylogeographic analysis of Blastomyces dermatitidis and Blastomyces gilchristii reveals an association with North American freshwater drainage basins. PLoS One. 2016. 11 (7):e0159396. [QxMD MEDLINE Link].

22. Baumgardner DJ, Buggy BP, Mattson BJ, Burdick JS, Ludwig D. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis. 1992 Oct. 15 (4):629-35. [QxMD MEDLINE Link].

23. Frean JA, Carman WF, Crewe-Brown HH, Culligan GA, Young CN. Blastomyces dermatitidis infections in the RSA. S Afr Med J. 1989 Jul 1. 76 (1):13-6. [QxMD MEDLINE Link].

24. Baily GG, Robertson VJ, Neill P, Garrido P, Levy LF. Blastomycosis in Africa: clinical features, diagnosis, and treatment. Rev Infect Dis. 1991 Sep-Oct. 13 (5):1005-8. [QxMD MEDLINE Link].

25. Anjorin FI, Kazmi R, Malu AO, Lawande RV, Fakunle YM. A case of blastomycosis from Zaria, Nigeria. Trans R Soc Trop Med Hyg. 1984. 78 (5):577-80. [QxMD MEDLINE Link].

26. Jerray M, Hayouni A, Benzarti M, Klabi N, Garrouche A. Blastomycosis in Africa: a new case from Tunisia. Eur Respir J. 1992 Mar. 5 (3):365-7. [QxMD MEDLINE Link].

27. Ferchichi L, Mekni A, Bellil K, et al. [Three cases of cutaneous blastomycosis] [French]. Med Mal Infect. 2006 May. 36 (5):285-7. [QxMD MEDLINE Link].

28. Rais H, Jghaimi F, Baalal H, et al. [Blastomycosis in Morocco: imported mycosis] [French]. Rev Pneumol Clin. 2012 Feb. 68 (1):45-9. [QxMD MEDLINE Link].

29. Roy M, Benedict K, Deak E, et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis. 2013 Sep. 57 (5):655-62. [QxMD MEDLINE Link].

30. Cano MV, Ponce-de-Leon GF, Tippen S, Lindsley MD, Warwick M, Hajjeh RA. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect. 2003 Oct. 131 (2):907-14. [QxMD MEDLINE Link].

31. Centers for Disease Control and Prevention (CDC). Blastomycosis--Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep. 1996 Jul 19. 45 (28):601-3. [QxMD MEDLINE Link].

32. Pfister JR, Archer JR, Hersil S, et al. Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res. 2011 Jun. 9 (2):57-65. [QxMD MEDLINE Link]. [Full Text].

33. Kaplan W, Clifford MK. Blastomycosis. I. A review of 198 collected cases in Veterans Administration hospitals. Am Rev Respir Dis. 1964 May. 89:659-72. [QxMD MEDLINE Link].

34. Varkey B. Blastomycosis in children. Semin Respir Infect. 1997 Sep. 12(3):235-42. [QxMD MEDLINE Link].

35. Schutze GE, Hickerson SL, Fortin EM, et al. Blastomycosis in children. Clin Infect Dis. 1996 Mar. 22 (3):496-502. [QxMD MEDLINE Link].

36. Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore). 1993 Sep. 72 (5):311-25. [QxMD MEDLINE Link].

37. Lemos LB, Baliga M, Guo M. Blastomycosis: The great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol. 2002 Jun. 6 (3):194-203. [QxMD MEDLINE Link].

38. Conces DJ Jr. Endemic fungal pneumonia in immunocompromised patients. J Thorac Imaging. 1999 Jan. 14 (1):1-8. [QxMD MEDLINE Link].

39. Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med. 1993 Oct 21. 329 (17):1231-6. [QxMD MEDLINE Link].

40. Kralt D, Light B, Cheang M, et al. Clinical characteristics and outcomes in patients with pulmonary blastomycosis. Mycopathologia. 2009 Mar. 167 (3):115-24. [QxMD MEDLINE Link]. [Full Text].

41. Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007 Dec. 9 (4):310-7. [QxMD MEDLINE Link]. [Full Text].

42. Mason AR, Cortes GY, Cook J, Maize JC, Thiers BH. Cutaneous blastomycosis: a diagnostic challenge. Int J Dermatol. 2008 Aug. 47 (8):824-30. [QxMD MEDLINE Link].

43. Alpern JD, Bahr NC, Vazquez-Benitez G, Boulware DR, Sellman JS, Sarosi GA. Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis. Open Forum Infect Dis. 2016 Apr. 3 (2):ofw078. [QxMD MEDLINE Link]. [Full Text].

44. Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest. 2002 Mar. 121(3):768-73. [QxMD MEDLINE Link].

45. Bialek R, Cirera AC, Herrmann T, Aepinus C, Shearn-Bochsler VI, Legendre AM. Nested PCR assays for detection of Blastomyces dermatitidis DNA in paraffin-embedded canine tissue. J Clin Microbiol. 2003 Jan. 41 (1):205-8. [QxMD MEDLINE Link]. [Full Text].

46. Kravitz GR, Davies SF, Eckman MR, Sarosi GA. Chronic blastomycotic meningitis. Am J Med. 1981 Sep. 71 (3):501-5. [QxMD MEDLINE Link]. [Full Text].

47. Girouard G, Lachance C, Pelletier R. Observations on (1-3)-beta-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces. J Med Microbiol. 2007 Jul. 56 (pt 7):1001-2. [QxMD MEDLINE Link].

48. Klein BS, Kuritsky JN, Chappell WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis. 1986 Jan. 133 (1):144-8. [QxMD MEDLINE Link].

49. Klein BS, Vergeront JM, Kaufman L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis. 1987 Feb. 155 (2):262-8. [QxMD MEDLINE Link].

50. Bradsher RW, Pappas PG. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J. 1995 Dec. 88 (12):1256-9. [QxMD MEDLINE Link].

51. Sekhon AS, Kaufman L, Kobayashi GS, Moledina NH, Jalbert M. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol. 1995 Mar-Apr. 33 (2):123-5. [QxMD MEDLINE Link].

52. Rozovsky K, Bunge M, Higgins R, Consunji-Araneta R, Alqublan L, Fanella S. Imaging patterns of pediatric pulmonary blastomycosis. AJR Am J Roentgenol. 2018 Dec 27. 1-9. [QxMD MEDLINE Link].

53. Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med. 1992 Nov. 93 (5):489-97. [QxMD MEDLINE Link].

54. Dismukes WE, Cloud G, Bowles C, for the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. Ann Intern Med. 1985 Dec. 103 (6 (pt 1)):861-72. [QxMD MEDLINE Link].

55. Pappas PG, Bradsher RW, Chapman SW, et al, for the The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis with fluconazole: a pilot study. Clin Infect Dis. 1995 Feb. 20 (2):267-71. [QxMD MEDLINE Link].

56. Ta M, Flowers SA, Rogers PD. The role of voriconazole in the treatment of central nervous system blastomycosis. Ann Pharmacother. 2009 Oct. 43 (10):1696-700. [QxMD MEDLINE Link].

57. Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis. 2010 Mar 15. 50 (6):797-804. [QxMD MEDLINE Link].

58. Lentnek AL, Lentek IA. Successful management of Blastomyces dermatitidis meningitis. Infect Med. 2006. 23:39.

59. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis. 2003 Sep 1. 37 (5):728-32. [QxMD MEDLINE Link].

60. Parente-Rocha JA, Bailao AM, Amaral AC, et al. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators Inflamm. 2017. 2017:9870679. [QxMD MEDLINE Link]. [Full Text].

61. Wuthrich M, Warner T, Klein BS. IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J Immunol. 2005 Oct 15. 175 (8):5288-97. [QxMD MEDLINE Link].

62. Nemeth NM, Campbell GD, Oesterle PT, Shirose L, McEwen B, Jardine CM. Red fox as sentinel for Blastomyces dermatitidis, Ontario, Canada. Emerg Infect Dis. 2016 Jul. 22 (7):1275-7. [QxMD MEDLINE Link]. [Full Text].

63. Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol. 2004 Oct. 42 (10):4873-5. [QxMD MEDLINE Link]. [Full Text].

Chidinma Chima-Melton, MD Assistant Clinical Professor in Pulmonary and Critical Care Medicine, UCLA Health; Burn Intensivist and Hospitalist, West Hills Hospital and Medical Center; Pulmonologist and Intensivist, Los Robles Medical Center and West Hills Hospital and Medical Center

Chidinma Chima-Melton, MD is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

Disclosure: Nothing to disclose.

Itzhak Brook, MD, MSc Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases,Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Michael Peterson, MD Chief of Medicine, Vice-Chair of Medicine, University of California, San Francisco, School of Medicine; Endowed Professor of Medicine, University of California, San Francisco-Fresno, School of Medicine

Michael Peterson, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

Gregory J Raugi, MD, PhD Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle School of Medicine; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle

Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Mark R Schleiss, MD Minnesota American Legion and Auxiliary Heart Research Foundation Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School

Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Avinash Shetty, MD Department of Pediatrics, Division of Pediatric Infectious Diseases, Assistant Professor of Pediatrics, Wake Forest University School of Medicine

Avinash Shetty, MD is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Basil Varkey, MD, FCCP Professor Emeritus, Department of Internal Medicine, Division of Pulmonary and Critical Care, Medical College of Wisconsin; Consulting Pulmonologist, Froedtert Memorial Lutheran Hospital

Basil Varkey, MD, FCCP is a member of the following medical societies: American Association of Physicians of Indian Origin and American College of Chest Physicians

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

What would you like to print?

• Print this section
• Print the entire contents of
• Print the entire contents of article